RuleMedi

By DUFOREST Ltd

  • Home
  • Solutions
    • Compass
    • Conductor
    • Catalyst
  • Platform
  • About
  • Contact

Multi-Jurisdictional Drug Development: Navigating FDA, EMA, and MHRA Divergence with Context Engineering

by admin | Dec 4, 2025 | Lab Notes

ABSTRACT –  The promise of global drug development—conducting a single pivotal trial that supports simultaneous regulatory submissions across the United States, European Union, and United Kingdom—has collided with the reality of regulatory divergence. Despite...

The EU MDR Bottleneck: How Agentic AI Solves the Notified Body Capacity Crisis

by admin | Dec 4, 2025 | Lab Notes

ABSTRACT –  The European Union’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have created an unprecedented certification bottleneck that threatens innovation, patient access, and the viability of medtech and biotech SMEs. With...

Hello world!

by admin | Nov 7, 2025 | Uncategorized

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Recent Posts

  • Multi-Jurisdictional Drug Development: Navigating FDA, EMA, and MHRA Divergence with Context Engineering
  • The EU MDR Bottleneck: How Agentic AI Solves the Notified Body Capacity Crisis
  • Hello world!

Recent Comments

  1. dtrtqrplmr on Hello world!
  2. A WordPress Commenter on Hello world!

RuleMedi

By DUFOREST Ltd

Sovereign agentic AI for the regulated life sciences industry. Turning regulatory complexity into strategic advantage.

SOLUTIONS

Compass

  • Clarity & Executiom

Conductor

  • Orchestration & Governance

Catalyst

  • Foresight & Advantage

COMPANY

Platform

  • Cloud, Sovereign Cloud, On-Premise

About

  • Duforest, RuleXis, Fyn

CONTACT



+44 (0) 73 8811 8811



info@rulemedi.com

Request a Demo ➜

© 2026 RuleMedi, a trading division of Duforest Ltd. All rights reserved.

Privacy Policy